Similar articles for PMID: 26681700

Year	Number of Results
1998	1
1999	2
2001	4
2002	1
2003	1
2004	2
2005	4
2006	3
2007	5
2008	8
2009	5
2010	4
2011	8
2012	2
2013	6
2014	3
2015	14
2016	6
2017	2
2019	4
2020	2
2022	1
2024	0

1

Reduced Effectiveness of Contraceptive Implants for Women Taking the Antiretroviral Efavirenz (EFV): Still Good Enough and for How Long?

Shelton JD. Shelton JD. Glob Health Sci Pract. 2015 Dec 8;3(4):528-31. doi: 10.9745/GHSP-D-15-00356. Glob Health Sci Pract. 2015. PMID: 26681700 Free PMC article.

2

The Rise and Fall of Efavirenz.

Cluck D, Lewis P, Durham SH, Hester EK. Cluck D, et al. J Int Assoc Provid AIDS Care. 2016 May;15(3):181-3. doi: 10.1177/2325957416629561. Epub 2016 Feb 8. J Int Assoc Provid AIDS Care. 2016. PMID: 26858315 Free article. No abstract available.

3

Comparing the effectiveness of efavirenz and nevirapine for first-line antiretroviral therapy in a South African multicentre cohort.

Bock P, Fatti G, Grimwood A. Bock P, et al. Int Health. 2013 Jun;5(2):132-8. doi: 10.1093/inthealth/iht002. Int Health. 2013. PMID: 24030113 Clinical Trial.

4

Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review.

Muñoz-Moreno JA, Fumaz CR, Ferrer MJ, González-García M, Moltó J, Negredo E, Clotet B. Muñoz-Moreno JA, et al. AIDS Rev. 2009 Apr-Jun;11(2):103-9. AIDS Rev. 2009. PMID: 19529750 Review.

5

Efavirenz in the therapy of HIV infection.

Rakhmanina NY, van den Anker JN. Rakhmanina NY, et al. Expert Opin Drug Metab Toxicol. 2010 Jan;6(1):95-103. doi: 10.1517/17425250903483207. Expert Opin Drug Metab Toxicol. 2010. PMID: 20001610 Free PMC article. Review.

6

A review of abacavir and efavirenz: new antiretroviral drugs to treat HIV-1 infection.

Wolbach J, Capoccia K. Wolbach J, et al. Nurse Pract. 1999 Jun;24(6):81-2, 87-90, 92. Nurse Pract. 1999. PMID: 10431297 Review. No abstract available.

7

Long-term efficacy and tolerance of efavirenz- and nevirapine-containing regimens in adult HIV type 1 Senegalese patients.

de Beaudrap P, Etard JF, Guèye FN, Guèye M, Landman R, Girard PM, Sow PS, Ndoye I, Delaporte E; ANRS 1215/1290 Study Group. de Beaudrap P, et al. AIDS Res Hum Retroviruses. 2008 Jun;24(6):753-60. doi: 10.1089/aid.2007.0295. AIDS Res Hum Retroviruses. 2008. PMID: 18507521

8

Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen.

Fischl MA, Collier AC, Mukherjee AL, Feinberg JE, Demeter LM, Tebas P, Giuliano M, Dehlinger M, Garren K, Brizz B, Bassett R. Fischl MA, et al. AIDS. 2007 Jan 30;21(3):325-33. doi: 10.1097/QAD.0b013e328011ddfa. AIDS. 2007. PMID: 17255739 Clinical Trial.

9

Efavirenz--still first-line king?

Best BM, Goicoechea M. Best BM, et al. Expert Opin Drug Metab Toxicol. 2008 Jul;4(7):965-72. doi: 10.1517/17425255.4.7.965. Expert Opin Drug Metab Toxicol. 2008. PMID: 18624683 Free PMC article. Review.

10

Long-term assessment of didanosine, lamivudine, and efavirenz in antiretroviral-naive patients: 3-year follow-up.

Santos J, Palacios R, Lozano F, López M, Gálvez MC, de la Torres J, López-Cortés LF, Ríos MJ, Rivero A; Grupo Andaluz Para el Estudio de las Enfermedades Infecciosas (GAEI). Santos J, et al. AIDS Res Hum Retroviruses. 2008 Jan;24(1):24-6. doi: 10.1089/aid.2007.0142. AIDS Res Hum Retroviruses. 2008. PMID: 18275344 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

81 results

Results by year